Literature DB >> 28937771

Urinary Metabolic Phenotyping of Women with Lower Urinary Tract Symptoms.

Rhiannon Bray1, Stefano Cacciatore, Beatriz Jiménez2, Rufus Cartwright1, Alex Digesu1, Ruwan Fernando1, Elaine Holmes, Jeremy K Nicholson, Phillip R Bennett3, David A MacIntyre, Vik Khullar1.   

Abstract

Lower urinary tract symptoms (LUTS), including urinary incontinence, urgency and nocturia, affect approximately half of women worldwide. Current diagnostic methods for LUTS are invasive and costly, while available treatments are limited by side effects leading to poor patient compliance. In this study, we aimed to identify urine metabolic signatures associated with LUTS using proton nuclear magnetic resonance (1H NMR) spectroscopy. A total of 214 urine samples were collected from women attending tertiary urogynecology clinics (cases; n = 176) and healthy control women attending general gynecology clinics (n = 36). Despite high variation in the urine metabolome across the cohort, associations between urine metabolic profiles and BMI, parity, overactive bladder syndrome, frequency, straining, and bladder storage were identified using KODAMA (knowledge discovery by accuracy maximization). Four distinct urinary metabotypes were identified, one of which was associated with increased urinary frequency and low BMI. Urine from these patients was characterized by increased levels of isoleucine and decreased levels of hippurate. Our study suggests that metabolic profiling of urine samples from LUTS patients offers the potential to identify differences in underlying etiology, which may permit stratification of patient populations and the design of more personalized treatment strategies.

Entities:  

Keywords:  KODAMA; LUTS; NMR; metabolic profiling; metabolomics; overactive bladder

Mesh:

Substances:

Year:  2017        PMID: 28937771     DOI: 10.1021/acs.jproteome.7b00568

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  4 in total

1.  A Novel Proteomics Approach to Identify Serum and Urinary Biomarkers and Pathways that Associate with Lower Urinary Tract Symptoms in Men and Women: Pilot Results of the Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN) Study.

Authors:  Brian T Helfand; Victor P Andreev; Nazema Y Siddiqui; Gang Liu; Bradley A Erickson; Margaret E Helmuth; Susan K Lutgendorf; H Henry Lai; Ziya Kirkali
Journal:  Urology       Date:  2019-03-25       Impact factor: 2.649

2.  Integrated Lipidomics and Proteomics Point to Early Blood-Based Changes in Childhood Preceding Later Development of Psychotic Experiences: Evidence From the Avon Longitudinal Study of Parents and Children.

Authors:  Francisco Madrid-Gambin; Melanie Föcking; Sophie Sabherwal; Meike Heurich; Jane A English; Aoife O'Gorman; Tommi Suvitaival; Linda Ahonen; Mary Cannon; Glyn Lewis; Ismo Mattila; Caitriona Scaife; Sean Madden; Tuulia Hyötyläinen; Matej Orešič; Stanley Zammit; Gerard Cagney; David R Cotter; Lorraine Brennan
Journal:  Biol Psychiatry       Date:  2019-01-30       Impact factor: 13.382

3.  Serum Concentrations of Citrate, Tyrosine, 2- and 3- Hydroxybutyrate are Associated with Increased 3-Month Mortality in Acute Heart Failure Patients.

Authors:  Sarah Stryeck; Michaela Gastrager; Vesna Degoricija; Matias Trbušić; Ines Potočnjak; Bojana Radulović; Gudrun Pregartner; Andrea Berghold; Tobias Madl; Saša Frank
Journal:  Sci Rep       Date:  2019-05-01       Impact factor: 4.379

4.  Metabolic syndrome is associated with prostate enlargement: a systematic review, meta-analysis, and meta-regression on patients with lower urinary tract symptom factors.

Authors:  Asma Omran; Bianca M Leca; Eduard Oštarijaš; Natasha Graham; Ana Sofia Da Silva; Zoulikha M Zaïr; Alexander D Miras; Carel W le Roux; Royce P Vincent; Linda Cardozo; Georgios K Dimitriadis
Journal:  Ther Adv Endocrinol Metab       Date:  2021-12-08       Impact factor: 3.565

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.